Mineralys CMO David Malcom Rodman sells 2,171 common shares worth $65,781.30 - MLYS News | RalliesMineralys CMO David Malcom Rodman sells 2,171 common shares worth $65,781.30
M
MLYS• Chief medical officer transaction details
- Mineralys Therapeutics Chief Medical Officer David Malcom Rodman exercised stock options for 2,171 shares at $16 on July 9, 2026.
- Rodman sold 2,171 shares at $30.3 on the same day.
- Directly held common stock totaled 57,733 shares following the transactions.
- Stock options held fell to 15,194 shares after the exercise.
